Cargando…

Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer

BACKGROUND: Ultra-central lung cancer (UCLC) is difficult to achieve surgical treatment. Over the past few years, stereotactic ablative radiotherapy (SABR) or stereotactic body radiotherapy (SBRT) obviously improved the clinical efficacy and survival of UCLC patients. However, the adapted scheme of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bin, Dong, Yang, Yu, Xuyao, Li, Fengtong, Wang, Jingsheng, Chen, Huaming, Niu, Zeqian, Song, Yongchun, Yuan, Zhiyong, Tao, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118536/ https://www.ncbi.nlm.nih.gov/pubmed/35600391 http://dx.doi.org/10.3389/fonc.2022.868844

Ejemplares similares

Clinical study on the influence of motion and other factors on stereotactic radiotherapy in the treatment of adrenal gland tumor
por: Wang, Jingsheng, et al.
Publicado: (2016)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

A deep learning approach for automatic tumor delineation in stereotactic radiotherapy for non-small cell lung cancer using diagnostic PET-CT and planning CT
por: Yu, Xuyao, et al.
Publicado: (2023)

Accuracy analysis of different dose calculation algorithms for locally advanced pancreatic cancer stereotactic body radiotherapy
por: Song, Yongchun, et al.
Publicado: (2023)

Analysis of clinical efficacy of CyberKnife(®) treatment for locally advanced pancreatic cancer
por: Song, Yongchun, et al.
Publicado: (2015)

Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapy
por: Dibs, Khaled, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Pan, Yang-Xun, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
por: Murrell, Donna H., et al.
Publicado: (2018)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Improving stereotactic radiotherapy (SRT) planning process for brain metastases by Cyberknife system: reducing dose distribution in healthy tissues
por: Xuyao, Yu, et al.
Publicado: (2020)

Commissioning and initial stereotactic ablative radiotherapy experience with Vero
por: Solberg, Timothy D., et al.
Publicado: (2014)

Efficacy and safety of stereotactic body radiotherapy for painful bone metastases: Evidence from randomized controlled trials
por: Wang, Zilan, et al.
Publicado: (2022)

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
por: Al-Shafa, Faiez, et al.
Publicado: (2019)

Safety and efficacy of stereotactic ablative brachytherapy as a salvage therapy for recurrent chest wall cancer: A retrospective, multicenter study
por: Huo, Bin, et al.
Publicado: (2023)

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
por: Regnery, Sebastian, et al.
Publicado: (2022)

Commentary: Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Li, Zhaonan, et al.
Publicado: (2021)

Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing
por: Greco, Carlo, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2023)

Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning Contours
por: Wong, Jordan, et al.
Publicado: (2021)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
por: Brunner, Thomas B., et al.
Publicado: (2021)

Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
por: Cooke, Rosie, et al.
Publicado: (2020)

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases
por: Shen, Yuxin, et al.
Publicado: (2021)

Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments
por: Tyler, Madelaine K.
Publicado: (2016)

Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy
por: Hong, Julian C., et al.
Publicado: (2013)

Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
por: Schullian, Peter, et al.
Publicado: (2019)

Precision Stereotactic Radiotherapy for Spinal Tumors: Mechanism, Efficacy, and Issues
por: Zhuang, Hongqing, et al.
Publicado: (2020)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
por: Salvestrini, Viola, et al.
Publicado: (2022)

Plan quality analysis of stereotactic ablative body radiotherapy treatment planning in liver tumor
por: Watcharawipha, Anirut, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study
por: Hiniker, Susan M., et al.
Publicado: (2019)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
por: Chen, Lily, et al.
Publicado: (2022)

Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer
por: Loi, Mauro, et al.
Publicado: (2020)

Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by a Cyberknife stereotactic radiosurgery (SRS) system
por: Yu, Xuyao, et al.
Publicado: (2020)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy
por: Han, Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cp2q4cl3j73c4ni6i04mh5ms8c